Core Diagnostics, Digistain collaborate to bring breast cancer risk profiling technology to India, Nepal, Bhutan, Bangladesh – ET HealthWorld
Gurugram: Central diagnosis announced its exclusive partnership with Digistain. The collaboration aims to bring the breast cancer risk profiling technologyDigistain, to India, Nepal, Bhutan and Bangladesh. Digistain is a digital solution for cancer classification and forecast, approved by the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom. Offers a fast, affordable and … Read more